Targeting breast cancer stem cells: fishing season open!

Breast Cancer Res. 2010;12(5):312. doi: 10.1186/bcr2636. Epub 2010 Sep 21.

Abstract

Studies describing the tumor as a hierarchically organized cell population have changed the classical oncogenesis view and propose new therapeutic strategies. Cancer stem cells (CSCs) are thought to sustain tumor initiation/maintenance, therapy resistance, and systemic metastases. Targeting this tumor cell population is crucial to achieve a true cancer cure. A large research effort is now aiming to develop drugs targeting CSCs, based either on a priori understanding of key pathways regulating CSC biology or on high-throughput screening to identify novel targets and compounds.

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Biomarkers, Tumor
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology
  • CD24 Antigen / analysis
  • Cadherins / antagonists & inhibitors
  • Cell Line, Tumor
  • Drug Discovery
  • Epithelial-Mesenchymal Transition / drug effects
  • Female
  • Humans
  • Hyaluronan Receptors / analysis
  • Molecular Targeted Therapy
  • NF-kappa B / metabolism
  • Neoplastic Stem Cells / drug effects*
  • Neoplastic Stem Cells / metabolism
  • Signal Transduction

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • CD24 Antigen
  • Cadherins
  • Hyaluronan Receptors
  • NF-kappa B